We are live on ! Find out more
LUNG icon

Pulmonx
LUNG

107 hedge funds and large institutions have $514M invested in Pulmonx in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 29

1.44% more ownership

Funds ownership: 93.76% → 95.21% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

2% less funds holding

Funds holding: 109 → 107 (-2)

40% less capital invested

Capital invested by funds: $861M → $514M (-$347M)

Holders
107
Holders Change
-2
Holders Change %
-1.83%
% of All Funds
1.8%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
20
Increased
46
Reduced
29
Closed
20
Calls
$3.02M
Puts
–
Net Calls
+$3.02M
Net Calls Change
-$6.54M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$39.1M
2
JG
Jefferies Group
New York
+$18.4M
3
PVI
Pura Vida Investments
New York
+$15.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.7M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.68M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$53.8M
2
MGM
Miura Global Management
New York
-$14.8M
3
PA
Perceptive Advisors
New York
-$13.3M
4
BlackRock
BlackRock
New York
-$6.79M
5
DM
Deerfield Management
New York
-$4.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
26
Stephens Inc
Arkansas
$4.03M – – –
Citadel Advisors
27
Citadel Advisors
Florida
$3.88M +$1.76M +85,518 +48%
Charles Schwab
28
Charles Schwab
California
$3.67M +$313K +15,196 +6%
Norges Bank
29
Norges Bank
Norway
$3.43M +$4.8M +233,100 New
SEI Investments
30
SEI Investments
Pennsylvania
$2.9M +$1.76M +85,412 +77%
Lord, Abbett & Co
31
Lord, Abbett & Co
New Jersey
$2.64M +$249K +12,078 +7%
BG
32
Bellevue Group
Switzerland
$2.55M -$65.4K -3,174 -2%
Two Sigma Investments
33
Two Sigma Investments
New York
$2.1M +$2.34M +113,676 +394%
CSS
34
Cubist Systematic Strategies
Connecticut
$1.87M +$2.47M +119,973 +1,631%
Squarepoint
35
Squarepoint
New York
$1.76M +$2.47M +119,686 New
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$1.48M -$1.67M -81,259 -45%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.43M +$289K +14,029 +17%
N
38
Nuveen
North Carolina
$1.28M -$268K -13,019 -13%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$1.16M +$1.63M +79,105 New
PP
40
PDT Partners
New York
$992K +$1.09M +53,142 +374%
Swiss National Bank
41
Swiss National Bank
Switzerland
$958K +$354K +17,200 +36%
AWGLSCP
42
ABG-WTT Global Life Science Capital Partners
Hong Kong
$886K – – –
DTL
43
Dynamic Technology Lab
Singapore
$854K +$1.2M +58,069 New
FG
44
Formula Growth
Quebec, Canada
$809K – – –
Bank of America
45
Bank of America
North Carolina
$806K +$61.5K +2,984 +6%
Qube Research & Technologies (QRT)
46
Qube Research & Technologies (QRT)
United Kingdom
$804K +$1.13M +54,651 New
MCM
47
Moore Capital Management
New York
$776K -$2.01M -97,506 -65%
BA
48
Bridgewater Associates
Connecticut
$763K +$228K +11,068 +27%
Voloridge Investment Management
49
Voloridge Investment Management
Florida
$739K +$1.03M +50,208 New
Ameriprise
50
Ameriprise
Minnesota
$701K -$326K -15,805 -25%
1
2
3 4 5

LUNG Hedge Fund Activity: Q2 2022 in Review

107 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q2 2022, worth a combined $514M — down 40% from $861M a quarter earlier.

Fund positioning in LUNG was balanced in Q2 2022: 20 funds opened new positions, 20 closed out, 46 added to existing stakes and 29 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $39.1M. The largest seller was Capital World Investors, cutting an estimated $53.8M.

  • 107 institutional investors held Pulmonx (LUNG) as of Q2 2022, down from 109 in Q1 2022.
  • Funds reported $514M of Pulmonx stock for Q2 2022, down 40% quarter-over-quarter.
  • 20 funds opened new Pulmonx positions in Q2 2022 and 20 closed out, a net change of 0 holders.
  • The largest Pulmonx buyer in Q2 2022 was Morgan Stanley, an estimated $39.1M added.
  • The largest Pulmonx seller in Q2 2022 was Capital World Investors, an estimated $53.8M sold.

Based on aggregated 13F filings for Q2 2022.